Michael C. Jensen
Impact in
- Oncology top 0.02%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 0.1%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Oncology 183
- CAR-T cell therapy research 179
- Immunology 84
- Immune Cell Function and Interaction 48
- Immunotherapy and Immune Responses 41
- T-cell and B-cell Immunology 14
- Co-authors
- Stanley R. Riddell (39 shared papers)Stephen J. Forman (47 shared papers)Rebecca Gardner (38 shared papers)Christine E. Brown (33 shared papers)Daniel W. Lee (2 shared papers)Nabil Ahmed (1 shared paper)David Porter (1 shared paper)Chrystal U. Louis (1 shared paper)
- Journals
- Blood (52 papers)Journal of Financial Economics (17 papers)Molecular Therapy (13 papers)Journal of Clinical Oncology (12 papers)Neuro-Oncology (10 papers)
- Partner nations
- United StatesGermanyBelgium
In The Last Decade
Michael C. Jensen
240 papers receiving 20.1k citations
Michael C. Jensen's Hit Papers
Peers
Comparison fields: 5 of 180
- Oncology 15.1k
- Immunology 6.1k
- Genetics 4.4k
- Genetics 1.2k
- Biomedical Engineering 4.3k
Countries citing papers authored by Michael C. Jensen
This map shows the geographic impact of Michael C. Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael C. Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael C. Jensen more than expected).
Fields of papers citing papers by Michael C. Jensen
This network shows the impact of papers produced by Michael C. Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael C. Jensen. The network helps show where Michael C. Jensen may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael C. Jensen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 257 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Current concepts in the diagnosis and management of cytokine release syndrome Hit paper breakdown → | 2014 | 1975 |
| 2 | Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma Hit paper breakdown → | 2006 | 1103 |
| 3 | Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults Hit paper breakdown → | 2017 | 812 |
| 4 | Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates Hit paper breakdown → | 2008 | 661 |
| 5 | Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma Hit paper breakdown → | 2015 | 606 |
| 6 | Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells Hit paper breakdown → | 2008 | 575 |
| 7 | Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy Hit paper breakdown → | 2016 | 559 |
| 8 | 2007 | 480 | |
| 9 | A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells Hit paper breakdown → | 2011 | 479 |
| 10 | T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells Hit paper breakdown → | 2016 | 469 |
| 11 | CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results Hit paper breakdown → | 2012 | 435 |
| 12 | 2010 | 432 | |
| 13 | Receptor Affinity and Extracellular Domain Modifications Affect Tumor Recognition by ROR1-Specific Chimeric Antigen Receptor T Cells Hit paper breakdown → | 2013 | 428 |
| 14 | 2014 | 414 | |
| 15 | 2006 | 397 | |
| 16 | 1995 | 319 | |
| 17 | 2013 | 307 | |
| 18 | 2016 | 302 | |
| 19 | 2004 | 291 | |
| 20 | 2008 | 280 |
About Michael C. Jensen
Michael C. Jensen is a scholar working on Oncology, Immunology, Molecular Biology, Genetics and Biomedical Engineering, having authored 257 papers that have together received 20.6k indexed citations. Recurring topics across this work include CAR-T cell therapy research (179 papers), Immune Cell Function and Interaction (48 papers), Immunotherapy and Immune Responses (41 papers), Virus-based gene therapy research (38 papers), Nanowire Synthesis and Applications (18 papers), Viral Infectious Diseases and Gene Expression in Insects (16 papers), T-cell and B-cell Immunology (14 papers) and RNA Interference and Gene Delivery (11 papers). The work is most often cited by research in Oncology (15.1k citations), Immunology (6.1k citations), Genetics (4.4k citations), Genetics (1.2k citations) and Biomedical Engineering (4.3k citations). Michael C. Jensen has collaborated with scholars based in United States, Germany and Belgium. Frequent co-authors include Stanley R. Riddell, Stephen J. Forman, Rebecca Gardner, Christine E. Brown, Daniel W. Lee, Nabil Ahmed, David Porter, Chrystal U. Louis, Crystal L. Mackall and Stephan A. Grupp. Their work appears in journals such as Blood, Journal of Financial Economics, Molecular Therapy, Journal of Clinical Oncology and Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.